Whitehawk Therapeutics (WHWK) Net Cash Flow (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported Net Cash Flow of -$2.8 million for Q1 2026, down 101.4% year-over-year from $198.8 million in Q1 2025, and down 665.29% on a QoQ basis from -$363000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) has 17 years of Net Cash Flow data on file, last reported at -$2.8 million in Q1 2026.
- Quarterly Net Cash Flow fell 101.4% year-over-year to -$2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$192.8 million (down 210.97% YoY) and the FY2025 annual result came in at $8.8 million, up 125.82% from the prior year.
- Net Cash Flow slipped to -$2.8 million in Q1 2026 per WHWK's latest filing, from -$363000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $198.8 million in Q1 2025 and bottomed at -$107.0 million in Q3 2025.
- The 5-year median for Net Cash Flow is -$5.9 million (2023), against an average of -$6.7 million.
- The widest annual swing landed in 2024, when Net Cash Flow sank 1753.98%; it then surged 2283.08% in 2025.
- Tracing WHWK's Net Cash Flow over 5 years: stood at -$95.8 million in 2022, then jumped by 93.83% to -$5.9 million in 2023, then surged by 68.44% to -$1.9 million in 2024, then surged by 80.56% to -$363000.0 in 2025, then tumbled by 665.29% to -$2.8 million in 2026.
- Per Business Quant, the three latest WHWK Net Cash Flow figures stand at -$2.8 million (Q1 2026), -$363000.0 (Q4 2025), and -$107.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -2.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.78 Mn |
| Mar 31, 2026 | -2.78 Mn |
| Dec 31, 2025 | -363,000.00 |
| Dec 31, 2025 | -363,000.00 |
| Sep 30, 2025 | -107.01 Mn |
| Sep 30, 2025 | -107.01 Mn |
| Jun 30, 2025 | -82.63 Mn |
| Jun 30, 2025 | -82.63 Mn |
| Mar 31, 2025 | 198.84 Mn |
| Mar 31, 2025 | 198.84 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -12.64 Mn |
| Jun 30, 2024 | -12.64 Mn |
| Mar 31, 2024 | -9.11 Mn |
| Mar 31, 2024 | -9.11 Mn |
| Dec 31, 2023 | -5.92 Mn |
| Dec 31, 2023 | -5.92 Mn |
| Sep 30, 2023 | 641,000.00 |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 34.12 Mn |
| Jun 30, 2023 | 34.12 Mn |
| Mar 31, 2023 | -4.97 Mn |
| Mar 31, 2023 | -4.97 Mn |
| Dec 31, 2022 | -95.80 Mn |
| Dec 31, 2022 | -95.80 Mn |
| Sep 30, 2022 | 16.08 Mn |
| Sep 30, 2022 | 16.08 Mn |
| Jun 30, 2022 | -11.05 Mn |
| Jun 30, 2022 | -11.05 Mn |
| Mar 31, 2022 | -19.14 Mn |
| Mar 31, 2022 | -19.14 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | 149.70 Mn |
| Sep 30, 2021 | 149.70 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Jun 30, 2021 | -3.26 Mn |
| Mar 31, 2021 | 10.63 Mn |
| Mar 31, 2021 | 10.63 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Dec 31, 2020 | -3.28 Mn |
| Sep 30, 2020 | -15.78 Mn |
| Sep 30, 2020 | -15.78 Mn |
| Jun 30, 2020 | 10.29 Mn |
| Jun 30, 2020 | 10.29 Mn |
| Mar 31, 2020 | -3.94 Mn |
| Mar 31, 2020 | -3.94 Mn |
| Dec 31, 2019 | -4.87 Mn |
| Dec 31, 2019 | -4.87 Mn |
| Sep 30, 2019 | -4.77 Mn |
| Sep 30, 2019 | -4.77 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Jun 30, 2019 | -5.27 Mn |
| Mar 31, 2019 | -9.19 Mn |
| Mar 31, 2019 | -9.19 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Sep 30, 2018 | 24,057.00 |
| Sep 30, 2018 | 24,057.00 |
| Jun 30, 2018 | 55.02 Mn |
| Jun 30, 2018 | 55.02 Mn |
| Mar 31, 2018 | -6.50 Mn |
| Mar 31, 2018 | -6.50 Mn |
| Dec 31, 2017 | -4.56 Mn |
| Dec 31, 2017 | -4.56 Mn |
| Sep 30, 2017 | -4.02 Mn |
| Sep 30, 2017 | -4.02 Mn |
| Jun 30, 2017 | -6.29 Mn |
| Jun 30, 2017 | -6.29 Mn |
| Mar 31, 2017 | 33.53 Mn |
| Mar 31, 2017 | 33.53 Mn |
| Dec 31, 2016 | 301,344.00 |
| Dec 31, 2016 | 301,344.00 |
| Sep 30, 2016 | -294,406.00 |
| Sep 30, 2016 | -294,406.00 |
| Jun 30, 2016 | -3.98 Mn |
| Jun 30, 2016 | -3.98 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Mar 31, 2016 | -3.98 Mn |
| Dec 31, 2015 | 12,259.00 |
| Dec 31, 2015 | 12,259.00 |
| Sep 30, 2015 | -3,825.00 |
| Sep 30, 2015 | -3,825.00 |
| Jun 30, 2015 | -13,192.00 |
| Jun 30, 2015 | -13,192.00 |
| Mar 31, 2015 | 18,024.00 |
| Mar 31, 2015 | 18,024.00 |
| Dec 31, 2014 | -12,604.00 |
| Dec 31, 2014 | -12,604.00 |
| Sep 30, 2014 | -1,701.00 |
| Sep 30, 2014 | -1,701.00 |
| Jun 30, 2014 | -1,315.00 |
| Jun 30, 2014 | -1,315.00 |
| Mar 31, 2014 | -400.00 |
| Mar 31, 2014 | -400.00 |
| Dec 31, 2013 | -4,012.00 |
| Dec 31, 2013 | -4,012.00 |
| Sep 30, 2013 | -8,125.00 |
| Sep 30, 2013 | -8,125.00 |
| Jun 30, 2013 | 15,714.00 |
| Jun 30, 2013 | 15,714.00 |
| Mar 31, 2013 | -1,901.00 |
| Mar 31, 2013 | -1,901.00 |
| Dec 31, 2012 | -784.00 |
| Dec 31, 2012 | -784.00 |
| Sep 30, 2012 | -3,920.00 |
| Sep 30, 2012 | -3,920.00 |
| Jun 30, 2012 | -14,287.00 |
| Jun 30, 2012 | -14,287.00 |
| Mar 31, 2012 | 19,473.00 |
| Mar 31, 2012 | 19,473.00 |
| Dec 31, 2011 | -2,005.00 |
| Dec 31, 2011 | -2,005.00 |
| Sep 30, 2011 | -3,100.00 |
| Sep 30, 2011 | -3,100.00 |
| Jun 30, 2011 | -15,404.00 |
| Jun 30, 2011 | -15,404.00 |
| Mar 31, 2011 | -2,264.00 |
| Mar 31, 2011 | -2,264.00 |
| Dec 31, 2010 | 24,644.00 |
| Dec 31, 2010 | 24,644.00 |
| Sep 30, 2010 | -3,506.00 |
| Sep 30, 2010 | -3,506.00 |